Investor Relations
Welcome to our dynamic visualization of the ongoing projects at Kamat Pharmatech. Below, you'll find a comprehensive table representing the current status of each project within our development pipeline. Each entry is color-coded to reflect its current stage of completion, allowing for an at-a-glance understanding of our progress and ongoing efforts.
| Pipeline Item | Pipeline Milestones | | Product Name | Regulatory Type | Dosage Form | Product Development | Technology Transfer | Regulatory Process | Commercialization | | 1 | Nystatin Oral Suspension, USP | ANDA§ | Oral Suspension | | | | | | | | | | | | | | | | | | | 2 | Raldesy (Trazodone Oral Solution) | 505(b)2 | Oral Solution | | | | | | | | | | | | | | | | | | | 3 | Confidential | ANDA§ | Long-Acting Injectable (LAI) | | | | | | | | | | | | | | | | | | | 4 | Confidential | ANDA§ | Lyophilized Vial | | | | | | | | | | | | | | | | | | | 5 | Confidential | ANDA | Lyophilized Vial | | | | | | | | | | | | | | | | | | | 6 | Confidential | ANDA | Ready-to-Use Injectable | | | | | | | | | | | | | | | | | | | 7 | Confidential | ANDA | Injectable | | | | | | | | | | | | | | | | | | | 8 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 9 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 10 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 11 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 12 | Confidential | 505(b)2 | Oral Suspension | | | | | | | | | | | | | | | | | | | 13 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 14 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 15 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 16 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 17 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 18 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 19 | Confidential | ANDA | Topical | | | | | | | | | | | | | | | | | | | 20 | Confidential | OTC | Oral Tonic | | | | | | | | | | | | | | | | | | | 21 | Confidential | OTC | Topical | | | | | | | | | | | | | | | | | | | 22 | Confidential | 505(b)2 | Nasal Spray | | | | | | | | | | | | | | | | | | | 23 | Confidential | ANDA | Ready-to-Use Injectable | | | | | | | | | | | | | | | | | | | 24 | Confidential | ANDA | Ready-to-Use Injectable | | | | | | | | | | | | | | | | | | | 25 | Confidential | | Lyophilized injectable | | | | | | | | | | | | | | | | | |
§ In collaboration with partner.We are actively expanding our capabilities through the development of a microsphere technology platform and specialized product manufacturing based in the US. Beyond our commercial ventures, we are committed to fostering innovation by supporting a select group of basic science projects and pioneering new product developments. If you're interested in collaborating on any of these initiatives, please don't hesitate to contact us. Upon signing a non-disclosure agreement (NDA), we can disclose further details and explore the possibility of collaboration. |